Advertisements

Atorvastatin Teva

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Atorvastatin Teva

The medicine Atorvastatin Teva is a pharmaceutical product strictly defined by its pharmacological classification and chemical structure, establishing its core role as a lipid-regulating agent. It is a synthetic small molecule drug provided as an oral film-coated tablet, a standard form for systemic administration.

Property Description
Active ingredient Atorvastatin (as the calcium salt)
Form Film-coated tablet (Oral)
Pharmacological class HMG-CoA reductase inhibitor (Statin)
Common purpose Management of high blood lipid levels (Dyslipidemia)
Origin Synthetic

What Type of Medicine is Atorvastatin Teva?

Atorvastatin Teva belongs to the class of prescription medicines known as Statins, formally categorized as HMG-CoA reductase inhibitors. This classification denotes that the drug functions specifically by impeding the rate-limiting enzyme in the body's internal synthesis of cholesterol within the liver. The product is a generic drug formulation manufactured by Teva Pharmaceutical Industries, a factor that ensures its bioequivalence to the original branded product.

Active Ingredient and General Benefit

The active ingredient is Atorvastatin, a compound that is clinically recognized for its capacity to deliver high-intensity reduction of Low-Density Lipoprotein (LDL) cholesterol and triglycerides. Atorvastatin is chemically distinguishable from older statins because of its high lipophilicity and long half-life, which supports the medicine's primary general purpose of managing dyslipidemia by maintaining controlled concentrations of harmful blood fats.

Regulatory References

  1. NIH DailyMed (Atorvastatin Calcium)
  2. NIH MedlinePlus (Atorvastatin)
Advertisements

What side effects are possible with Atorvastatin Teva?

Possible Side Effects and Safety Information

This section details the officially documented adverse reactions and safety constraints of Atorvastatin, strictly based on regulatory prescribing information from government authorities.


Documented Adverse Reactions

The most frequent side effects are classified as Common (ge 1/100 to < 1/10) and often involve systemic and musculoskeletal issues. These include myalgia (muscle pain), arthralgia (joint pain), nasopharyngitis, headache, and gastrointestinal effects like diarrhea and nausea.

Rare (ge 1/10,000 to < 1/1,000) and Very Rare (< 1/10,000) effects cover significant conditions such as thrombocytopenia, peripheral neuropathy, and hepatic failure.


Serious Safety Considerations

The official labeling highlights rare but severe adverse reactions requiring attention, primarily affecting the liver and muscle tissue. These include Rhabdomyolysis, a serious muscle condition that may lead to kidney damage, and Hepatic Failure, a rare but documented liver complication. The risk of myopathy is known to increase with the co-administration of certain medications.


Population-Specific Safety Constraints

Atorvastatin is formally contraindicated in several specific populations and conditions as defined by regulatory agencies. This includes individuals with active liver disease or persistent, unexplained elevations in liver enzymes. It is also contraindicated during pregnancy and lactation due to potential fetal harm, and women of child-bearing potential must use appropriate contraception. The risk of muscle issues is also noted as being higher in older adults (ge 65 years).

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation describes Atorvastatin overdosage as a high-exposure event that may increase the risk of serious adverse effects involving the muscles and liver. Risk factors that increase the potential for severe outcomes include advanced age (>65 years), renal impairment, and uncontrolled hypothyroidism.

Documented Overdose Manifestations

Overdosage may lead to manifestations consistent with muscle or liver toxicity. Officially documented clinical signs include unexplained muscle pain, tenderness, or weakness, which may be accompanied by malaise or fever. Signs of liver injury include jaundice (yellowing of the skin or eyes) and hyperbilirubinemia. Laboratory findings associated with toxicity include markedly elevated Creatine Kinase (CK) levels (greater than 10 times the Upper Limit of Normal) and increases in serum transaminases.

Serious Outcomes and Emergency Action

The most serious potential outcomes documented are rhabdomyolysis, a severe muscle injury that can lead to acute kidney injury, and rare reports of fatal and non-fatal hepatic failure.

In the event of a suspected overdosage, regulatory guidance mandates that patients or caregivers call a doctor or Poison Control Center immediately or go to the nearest emergency room right away. The drug must be promptly discontinued if serious injury is suspected.

Supportive Management and Antidote

The official labeling states that no specific treatment or antidote for Atorvastatin overdosage is known. Management should be symptomatic and consist of supportive measures instituted as required. Due to high plasma protein binding, hemodialysis is not expected to significantly enhance clearance of the drug.

Advertisements

Therapeutic Uses of Atorvastatin Teva

What Atorvastatin Teva Treats: Main Uses and Benefits

Atorvastatin Teva is used for managing conditions characterized by elevated fat (lipid) levels in the blood, and is considered relevant for easing the overall systemic burden associated with cardiovascular risk factors.

Atorvastatin is applied in areas where additional symptomatic support is needed by assisting with the management of elevated low-density lipoprotein (LDL) and triglycerides.


Management of Abnormal Blood Lipids

This therapeutic domain is commonly used across conditions presenting with systemic or localized discomfort related to unhealthy lipid levels, such as primary hypercholesterolemia and mixed dyslipidemia, which are conditions involving systemic imbalance. Atorvastatin helps address symptom clusters that may become intense or disruptive by assisting with the management of elevated lipid parameters. This contributes to easing the overall symptom load and assists with maintaining functional stability.


Supportive Cardiovascular Protection

Atorvastatin is applied in clinical settings that involve acute or unstable symptom patterns, especially in patients with an increased risk of heart and blood vessel problems, including those with coronary heart disease or type 2 diabetes who have multiple risk factors. The medicine provides supportive relief and is relevant when supportive symptom management is appropriate in contexts involving heightened systemic burden.

Quick Fact: May assist with symptoms related to systemic imbalance

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Atorvastatin Teva — Official Regulatory Information

The eligibility for Atorvastatin Teva is determined by official regulatory criteria related to physiological state, age, and organ function, establishing who is permitted to use the medicine and who is absolutely restricted.


Contraindicated Populations (Must Not Use)

Eligibility Status Official Population/Condition
Contraindicated Active Liver Disease or unexplained persistent transaminase elevations.
Contraindicated Pregnancy (due to potential fetal harm).
Contraindicated Lactation (Breastfeeding).
Contraindicated Hypersensitivity to atorvastatin or any excipients.

Age-Related and Conditional Eligibility

Age-Related Rules Condition-Specific Rules
Adults ( 18 years) and Older Adults (permitted use). Renal Impairment (permitted use, no dose adjustment required).
Pediatric ( 10 years): Permitted for specific conditions (e.g., HeFH). History of Liver Disease/Alcoholism (use with caution).
Children (<10 years): Use not established. Predisposing factors for Myopathy (use with caution).
Females of Childbearing Potential must use adequate contraception.

Connection to the Overall Eligibility Profile

Regulatory documents define eligibility through strict prohibitions, primarily for active liver disease and physiological states like pregnancy and breastfeeding. Use is permitted for adults, while pediatric use is limited to those aged 10 and older for specific indications. For all eligible populations, official labeling imposes conditional restrictions, such as using the medicine with caution in the presence of risk factors for myopathy or a non-active history of liver disease.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Atorvastatin Teva's interaction profile is primarily governed by medicines and substances that alter its plasma concentration or increase the documented risk of specific adverse effects, as stated in official regulatory documents.

Contraindicated Combinations and Restrictions

Classification Interacting Agent Official Restriction/Outcome
Contraindicated Glecaprevir/Pibrentasvir Combination is prohibited [FDA/EMA].
Additive Risk Fibrates (e.g., Gemfibrozil), Colchicine, Niacin (geq1 g/day) Increases the documented risk of myopathy/rhabdomyolysis [FDA].
Exposure Increase Cyclosporine, Tipranavir plus Ritonavir Avoid co-administration due to increased plasma concentrations [FDA].

Pharmacokinetic and Substance Interactions

The co-administration of Potent CYP3A4 Inhibitors (e.g., Clarithromycin, Itraconazole, certain HIV/HCV protease inhibitors) or OATP Transporter Inhibitors significantly increases the systemic exposure of Atorvastatin, necessitating documented dose limits on Atorvastatin. CYP3A4 Inducers like Rifampin or St. John's Wort can potentially reduce Atorvastatin plasma concentrations. Rifampin specifically requires simultaneous co-administration to prevent a reduction in its concentration [FDA/SmPC]. Consumption of Grapefruit Juice in large quantities (over 1.2 liters per day) is officially restricted, as it increases plasma concentrations of Atorvastatin. Furthermore, the combination may increase plasma levels of Oral Contraceptives and Digoxin, and high alcohol intake is associated with liver injury [FDA]. Plasma concentrations of Atorvastatin are markedly increased in patients with chronic alcoholic liver disease [FDA].

Advertisements

Mechanism of Action

How Atorvastatin Teva Works

The mechanism of Atorvastatin is highly specific, primarily targeting internal biochemical processes to achieve systemic effects on the modulation of lipid concentration and vascular endothelial function.


Inhibition of Internal Cholesterol Synthesis

The drug acts as a competitive inhibitor of the enzyme HMG-CoA reductase in the liver, which controls the rate-limiting step of the mevalonate pathway (the route for internal cholesterol production). This action limits the precursors needed for cholesterol synthesis, which reduces the concentration of cholesterol within the hepatocyte.

⬆️ Enhanced LDL Clearance via Receptor Upregulation

As a direct consequence of reduced internal synthesis, the hepatocyte triggers a compensatory feedback loop, increasing the surface expression of Low-Density Lipoprotein (LDL) receptors. This physiological response accelerates the clearance and removal of LDL cholesterol particles from the circulating bloodstream.

Non-Lipid Vascular Wall Modulation

Beyond lipid reduction, the inhibition mechanism indirectly affects the non-sterol isoprenoid pathways, altering small regulatory proteins essential for vascular function. This results in the modulation of inflammation and altered function of the endothelial lining of blood vessels, contributing to systemic vascular effects independent of cholesterol lowering.

Advertisements

Dosage and Administration Information

Atorvastatin Teva is prescribed as a long-term oral film-coated tablet intended for once-daily administration. The medicine's use is structured by standards that prioritize convenience and consistency. The standard protocol for administration establishes a flexible intake schedule: the tablets may be taken at any time of the day, and administration is permitted with or without food. The medicine is officially used as an adjunct to a cholesterol-lowering diet, which is a prerequisite for initiating treatment.


Dosing Schedule and Adjustment

The initial adult dose is typically 10 mg or 20 mg taken once daily. The standard maintenance dose ranges from 10 mg up to the maximum daily allowance of 80 mg. Dosage titration is a methodical process guided by therapeutic response. Adjustments should only be considered after at least four weeks of treatment at the current dosage, allowing sufficient time to assess the effect on lipid parameters.

Population Usual Starting Dose Maximum Daily Dose
Adults (General) 10 mg or 20 mg once daily 80 mg
Pediatric (≥ 10 years, HeFH) 10 mg once daily 20 mg

Administration Rules

The official instructions address specific circumstances of use. If a dose is missed, the patient should skip the missed dose and resume with the next scheduled daily dose; no double dosing is prescribed to compensate for the skipped amount. Product information also confirms that no adjustment to the dose is required for patients with renal impairment.

Advertisements

Recent Clinical Evidence

Overview of Clinical Research

Atorvastatin has been extensively studied in large, global randomized controlled trials (RCTs) to evaluate its impact on lowering lipid levels and reducing the risk of cardiovascular events. The clinical evidence supports its use in both primary prevention (patients with risk factors but no established coronary heart disease) and secondary prevention (patients with established coronary heart disease).

Key Findings from Studies

Research consistently shows that atorvastatin reduces levels of low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol,' which is the primary therapeutic goal. Landmark trials, such as the TNT (Treating to New Targets) trial, examined intensive lipid lowering and observed a reduced incidence of major cardiovascular events, including non-fatal myocardial infarction, stroke, and revascularization procedures.

Primary Area of Research Observed Effect in Trials
Cardiovascular Risk Reduction Association with a reduction in the risk of myocardial infarction (heart attack) and stroke in high-risk patients.
Dyslipidemia Lowering of LDL-C and triglycerides; increase in high-density lipoprotein cholesterol (HDL-C).

Safety Profile Observations

Across the clinical trial program, atorvastatin was generally well-tolerated. The safety profile is similar to other medicines in the statin class. The most frequently observed adverse events reported in patients included headache, gastrointestinal symptoms, and myalgia (muscle aches).

Findings from clinical trials show that the risk of severe muscle-related problems, such as rhabdomyolysis, is low. Furthermore, research has demonstrated that elevations in liver enzymes, while monitored, are generally transient and rarely lead to a need for treatment discontinuation.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Atorvastatin Teva (FAQ)


Q: Does Atorvastatin Teva have any ingredients besides the active drug?

Yes, official product information indicates that Atorvastatin Teva tablets contain the active ingredient (atorvastatin) along with several inactive ingredients, or excipients.

These excipients can include substances like calcium carbonate, microcrystalline cellulose, and magnesium stearate, which are added for stability and to form the tablet.


Q: Is Atorvastatin Teva considered a high-intensity statin?

According to established medical guidelines cited in regulatory contexts, atorvastatin is classified based on the dose administered.

Higher strength doses of atorvastatin are generally classified as high-intensity therapy. This classification means the doses are associated with a greater ability to reduce LDL cholesterol levels.


Q: How is Atorvastatin Teva different from the standard Atorvastatin drug?

Atorvastatin Teva is a generic version of the medicine atorvastatin.

Regulatory authorities consider generic versions to be bioequivalent to the original branded drug, meaning they contain the same active ingredient and are considered therapeutically equivalent by regulatory authorities.


Q: Does Atorvastatin Teva affect blood sugar levels?

Regulatory warnings indicate that statins, including atorvastatin, may lead to increases in both fasting serum glucose (blood sugar) and HbA1 c levels.

Official labels were revised to reflect the possibility of increased blood sugar and new-onset diabetes mellitus in some individuals, as noted in observational data.


Q: Can Atorvastatin Teva cause sleep problems or insomnia?

Studies and official adverse reaction lists note that sleep-related disturbances have been reported with atorvastatin use.

Insomnia (difficulty sleeping) is listed as an uncommon side effect in the official product information.


Q: Can Atorvastatin Teva cause hair loss?

Alopecia (hair loss) has been reported in post-marketing surveillance for atorvastatin.

Official documents classify hair loss as a very rare side effect of the medicine.


Q: Is Atorvastatin Teva a lifetime medication, or can it be stopped?

Atorvastatin is described in regulatory documents as a long-term medication.

Clinical evidence shows that therapeutic benefits are maintained through long-term and consistent use.


Q: What kind of monitoring is described in official sources for patients taking Atorvastatin Teva?

Official labeling states that liver enzyme testing is noted as a consideration prior to starting treatment with atorvastatin.

Official documents also indicate that these tests may be repeated periodically thereafter, or as clinically indicated.


Q: Are there any known sexual side effects associated with Atorvastatin Teva?

Regulatory sources list sexual dysfunction, which may include decreased libido or issues with erectile function, as an uncommon side effect.

These effects are generally noted from post-marketing reports associated with statin use.


Q: Can Atorvastatin Teva interact with over-the-counter pain relievers?

The drug is known to interact with certain medications that increase the risk of muscle-related side effects.

The regulatory label specifically notes an increased risk of myopathy when atorvastatin is co-administered with Colchicine, a medicine sometimes used for inflammatory conditions.


Q: Is the Teva brand of atorvastatin considered the same as the original drug?

Yes, regulatory agencies approve generic medicines like Atorvastatin Teva only after confirming that they are bioequivalent to the original product.

This means that the Teva brand is considered by regulators to be bioequivalent and therapeutically equivalent to the original drug.


Q: Are there any warnings about using Atorvastatin Teva before or after surgery?

Official patient instructions note the importance of communicating your use of atorvastatin to the healthcare team when planning a major surgical procedure.

The decision on whether to interrupt or continue therapy around the time of surgery is made by a healthcare professional.


Q: Does Atorvastatin Teva interact with blood pressure medications?

Yes, atorvastatin interacts with medicines that inhibit the CYP3A4 enzyme, which includes some calcium channel blockers used for blood pressure, such as diltiazem and verapamil.

Co-administration may increase the plasma concentration of atorvastatin, which is a factor healthcare professionals take into account when prescribing.


Q: Is it described that Atorvastatin Teva can cause memory problems?

Rare, post-marketing reports of cognitive impairment have been associated with statin use, including atorvastatin.

Official labeling notes that these effects, such as memory loss and confusion, are generally non-serious and are reversible upon stopping the medicine.


Q: What should be done if a severe reaction to Atorvastatin Teva is suspected?

Official labels state the importance of promptly reporting certain severe symptoms to a healthcare professional.

Symptoms like unexplained or persistent muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever, are noted in the official documents as requiring immediate attention.


Q: What are the general expectations for the long-term use of Atorvastatin Teva?

Clinical studies show that the major benefits of atorvastatin, especially the reduction of cardiovascular risk, are sustained over time.

Clinical evidence indicates that the protective benefits are maintained through long-term, consistent therapy over many years.


Q: Can Atorvastatin Teva be split or crushed if swallowing is difficult?

The official patient information for the tablets indicates that specific strengths (20 mg, 40 mg, and 80 mg) can be divided into equal doses.

However, the split portions are noted as needing to be swallowed whole with a drink of water.


Q: Does Atorvastatin Teva interact with antacids or stomach medications?

Clinical pharmacology studies note that the simultaneous use of atorvastatin with an oral antacid suspension containing magnesium and aluminum hydroxides decreases the plasma concentration of atorvastatin.

This potential interaction is a factor that should be discussed with a doctor or pharmacist.


Q: Is there a known link between Atorvastatin Teva and skin rash?

Yes, official documentation lists skin rash as an uncommon adverse reaction associated with atorvastatin.

This information is based on observations gathered during clinical trials and post-marketing experience.


Q: Are there specific ethnic or population groups described as having different responses to Atorvastatin Teva?

Regulatory guidance mentions that certain populations are noted as potentially having an increased risk of muscle-related side effects (myopathy).

This potential difference is a factor that healthcare professionals may consider when determining an appropriate dose.


Q: What kind of cholesterol levels are typically mentioned in studies of Atorvastatin Teva?

Studies of atorvastatin typically focus on its ability to cause a significant percentage reduction in LDL-C.

Research evidence in the regulatory labeling details the expected reduction range in LDL cholesterol achieved with different doses.


Q: Are there different classifications of statins, and where does Atorvastatin Teva fit?

Atorvastatin Teva is classified as an HMG-CoA reductase inhibitor, which is the formal name for the class of drugs commonly known as statins.

These medicines work by blocking the key enzyme in the liver responsible for producing cholesterol.


Q: Is it common for people to stop taking Atorvastatin Teva because of side effects?

In clinical trials, a small number of patients stopped taking atorvastatin due to adverse reactions.

The most common adverse reactions leading to discontinuation in studies were diarrhea and myalgia (muscle pain).

Advertisements

How should Atorvastatin Teva be stored and disposed of?

How to Store Atorvastatin Teva

Official regulatory documents mandate specific conditions to protect the medicine's stability:

Storage Requirement Official Condition
Temperature Store below 30 C and keep from freezing.
Protection Store away from excessive heat, moisture, and direct light.
Packaging Keep the medicine in its original container, tightly closed, and in the outer carton.
Child Safety Keep this medicine out of the sight and reach of children.

Disposal Instructions

Atorvastatin Teva must not be used after the expiry date (EXP) stated on the package. To safely dispose of any unused or expired tablets, do not throw the medicine into household waste or flush it down the toilet or sink, as this can affect the environment. The official instruction is to return the unused product to a pharmacist or an authorized collection point for proper pharmaceutical waste management.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atorvastatin Teva found in:

A-Z Index: